Best secure web gateway for healthcare - Zscaler or Cisco SSE?

I'm the lead cloud architect at a regional hospital network, about 3,000 employees. We migrated from on-prem proxies to Zscaler ZIA for our dev and clinical web traffic three years ago, and we later piloted Cisco SSE for six months before committing fully.

1. **API and Policy as Code Maturity:** Zscaler's API is a full REST interface with Terraform provider support. We scripted 90% of our policy deployment (URL categories, DLP rules for PHI patterns) and can replicate rule sets between our dev and prod tenant instances in about 20 minutes. Cisco SSE's API coverage is improving but was more fragmented; Umbrella had its APIs, Secure Firewall needed different ones, and stitching them together required more custom glue code.

2. **Latency Impact on Clinical Imaging Web Apps:** For cloud-hosted PACS viewers, Zscaler's direct-to-cloud proxy architecture added 8-12ms of latency over a direct connection from our facilities. Cisco SSE (using Umbrella with on-prem Secure Firewall tunnels) added 22-35ms, as traffic backhauled to our data center for inspection. The bigger issue was throughput: Zscaler scaled linearly for us, while our Secure Firewall clusters needed an upgrade (at $45k in list price) to handle the sustained 1.2 Gbps load from imaging studies without packet loss.

3. **Medical IoT and Non-Standard Device Traffic:** This is where Cisco's hybrid model can shine, but only if you invest. We have bedside monitors that only speak TLS 1.0. Zscaler rejected the traffic outright, as it should for security. We had to build a separate, segmented VLAN. With Cisco, we could create a bypass policy on the on-prem firewall for that specific IoT VLAN, which was operationally easier for our network team. For modern devices, however, Zscaler's clientless onboarding for BYOD was simpler for visiting physician devices.

4. **Real Cost Beyond List Price:** Zscaler was roughly $6.50 per user per month for the features we needed, but that required a direct internet egress at every location (we use SD-WAN). Cisco SSE came in around $5.25 per user per month for the suite, but that didn't include the hidden 18% annual uplift for firewall hardware support and the operational overhead of managing the inspection nodes. The total three-year cost projection was within 10% for our size, making the decision more about architecture.

Given your cloud-first directive and the performance requirement for clinical imaging, I'd recommend Zscaler, assuming your network team can handle the shift to local internet breakouts. If your clinical environment has a huge population of legacy, non-compliant IoT devices and you have strong on-prem network staff, lean toward Cisco SSE. To decide, tell us the count of your unique physical clinic locations and whether your existing firewalls are already due for a refresh cycle.

You're asking the right questions, especially the bit about hands-on experience over sales sheets. My two cents on your specific points:

I've seen too many teams get locked into a "clean architecture" without running the real numbers on what that proxy traffic will actually cost month-to-month. Zscaler's cloud-first model is elegant until you get the first bill for inspecting terabytes of clinical image data flowing to cloud PACS systems. Have you modeled the egress costs from your CSPs to their nearest proxy points, and can you quantify the performance hit if the nearest Zscaler node is two regions away?

For the medical IoT traffic, neither solution is a silver bullet. Those devices often have terrible, outdated TLS stacks that break under deep inspection. You'll spend more engineering time building bypass lists and exception policies than you think. Cisco's hardware integration might simplify that segmentation if you've already got the gear.

Did the vendor quotes include the reserved commit or savings plan options for the data inspection volume, or are they just giving you the on-demand list price? That's usually where the real negotiation starts.

Great point about the egress costs. Most folks forget that until the first cloud bill shock hits.

I ran a 30-day PoC with a cloud PACS vendor and Zscaler. The cost of moving those image previews from our regional Azure instance to the nearest ZIA node was a 40% premium over baseline egress, just for the hop. The Cisco side was cheaper on that front, but we had to deal with the extra ops overhead for the hybrid setup.

> building bypass lists and exception policies
Too real. We had an entire runbook just for MRI machine traffic. The TLS errors were a mess. Vendor quotes never include that level of support cost, it's all "here's the licensing SKU."

Did your team find the savings plan discounts were negotiable after you showed them the modeled egress data?

Yep, we used that modeled data as a major negotiation lever. The savings plan discount got 15% deeper after presenting the numbers. The real win was getting them to commit to a fixed-price band for the first 18 months while we optimized traffic flows.

Your 40% egress premium lines up with what we saw. It's a hidden tax on the "clean" cloud model. The MRI runbook problem is universal - we ended up fingerprinting devices by JA3 hash and building a separate, minimal policy group for them.

Everybody's stuck on comparing feature checkboxes. You're asking about hands-on experience, but then immediately framing it as "Zscaler or Cisco."

The real question you need to answer first is: what's your actual traffic pattern? If most of your clinical app traffic is east-west between your data center and a regional cloud provider, forcing it out to a Zscaler node just to come back in is architecturally stupid, no matter how clean the API is.

You mentioned existing network hardware. That's not just an "integration" perk. It's a massive cost avoidance. Deploying a hybrid model might feel messy, but it keeps high-volume, predictable flows local. Save the cloud proxy for the truly unpredictable user web traffic.

Also, "Zero Trust is non-negotiable" - good. But neither of these products gives you that out of the box. It's a deployment model, not a SKU. You can screw up a Zero Trust rollout with either vendor if you just bolt them onto a legacy network design.

That's a really smart question about scripting policy for PHI rules. I'm just getting into this myself with our move to Asana and ClickUp.

Do you have a separate dev and prod tenant for testing those automated policy changes? I'd be so nervous pushing a new DLP rule straight to clinical traffic without a safe sandbox.

Absolutely, a separate dev tenant is crucial. We learned that the hard way when a badly configured rule in our ClickUp setup briefly blocked an entire marketing team.

How do you handle syncing rule sets between your sandbox and production? I'm still trying to figure out a reliable process without manual copying.

Totally agree on using the modeled data as leverage. We did something similar and got a committed egress credit for the first year, which smoothed the budget shock.

That MRI runbook mention hits home. We found that creating a separate, geo-aware proxy group just for our imaging devices and clinical IoT, with relaxed TLS inspection, was the only way to stop the alert storms. It's not ideal from a pure Zero Trust stance, but you gotta pick your battles.

Did your PoC track any performance delta for the clinicians, or was it purely a cost/compliance exercise? Sometimes that 40% premium also comes with a lag that the radiologists will notice immediately.

You've hit on the critical tension. That clean Zscaler proxy architecture is fantastic for policy-as-code, which we love, but the "cloud-first" bit can become a liability with clinical imaging traffic. The API scripting is a dream compared to Cisco's fragmented approach, but you can't script away physics or cloud egress fees.

If Zero Trust is truly non-negotiable, remember that both will require you to build extensive bypass lists for medical IoT anyway. So the real evaluation is whether the operational simplicity of Zscaler's single control plane outweighs the cost and latency of hair-pinning all that internal-to-cloud traffic out to their nodes.

For your specific ask on hands-on pipeline experience: we built our policy deployment entirely via Terraform against ZIA, but we also had to build a separate pipeline to manage the ever-growing exception list for device traffic. It's two automation stacks, not one.

That point about modeling costs before committing is so true. We almost fell into the same trap with a different cloud-first vendor, not Zscaler.

> have you quantified the performance hit
We did, and the radiology team noticed the latency for thin-client EHR access immediately. It wasn't huge, maybe 80-120ms added, but enough for them to file complaints. That's when we started looking at hybrid architectures for specific app categories.

And yeah, the savings plan was a separate conversation entirely! Our first quote was just the standard license SKUs. Getting the committed data inspection tiers took two more meetings.

That 80-120ms hit is the silent killer for user adoption. We saw the same thing with cardiology image review over Citrix. It's not even about the raw speed, it's the perceived lag when a clinician is clicking through dozens of images.

We ended up creating a dedicated "Clinical Imaging" forwarding profile that bypasses the full proxy stack, just routing directly over private link. It's a carve-out, but it kept the performance complaints at zero.

The savings plan point is key though - getting those committed inspection tiers locked in upfront is often the only way to make the full proxy model viable for everything else.

> How do you handle syncing rule sets between your sandbox and production?

We treat security policy as infrastructure code for exactly this reason. Our DLP rule sets are defined as Terraform modules or, in some cases, Ansible playbooks, depending on the specific gateway component. We maintain a central Git repository where any change is peer-reviewed via a pull request. The pipeline is straightforward: the change is applied to the dev tenant first. After validation, the same approved commit triggers a separate pipeline job that applies it to production.

The critical nuance for healthcare is versioning and tagging rules with specific PHI identifiers or compliance frameworks. A single rule module might have tags for both `HIPAA` and `MRI-Device-Bypass`. This lets us audit, in code, exactly which policies were synced and why. It also prevents the manual drift you're trying to avoid, as the sandbox and production tenants are both generated from the same declarative source.

We did have to build a lightweight abstraction layer for the vendor APIs, as Zscaler's and Cisco's are quite different. The pipeline logic stays the same, but the backend execution module swaps out.

Zscaler's API is fully scriptable via Terraform, which we use for policy-as-code. However, their proxy model will add latency for clinical imaging apps if the traffic pattern is internal-to-cloud. You need to test that exact flow.

Cisco's SSE API feels bolted-on, but you can keep high-volume imaging traffic local via your existing hardware. That's the performance trade-off.

For medical IoT, both will require bypass lists. Neither product gracefully handles legacy device traffic without significant exemptions, undermining the "non-negotiable" Zero Trust stance.

Zero Trust is non-negotiable, you say? Then you need to talk to the clinical teams before you commit. Zscaler's "cleaner" architecture will murder your imaging app performance unless you pay for premium egress tiers or build carve-outs, which defeats the point.

* API/Scriptability: Zscaler's API is good, Cisco's is bad. But Terraforming a bad performance penalty doesn't fix it.
* Real-world latency: Add 80-120ms for thin-client clinical apps. Radiologists will notice. You'll end up building direct routing for imaging anyway.
* Medical IoT traffic: Both require massive bypass lists. The "deep inspection for PHI" dream dies there.

You're choosing between a modern plane with high fuel costs and a cheaper bus that needs constant repair. Model the egress costs and performance impact for your exact clinical app paths before you get sold on architecture diagrams.